Literature DB >> 26338372

Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction.

Rosita Zakeri1, Selma F Mohammed2.   

Abstract

Despite increasing recognition of the importance of right ventricular (RV) dysfunction (RVD) in the pathophysiology of left heart disease, our understanding of its epidemiology in heart failure (HF) with preserved ejection fraction (HFpEF) remains incomplete. In part, this is due to complex RV geometry and challenging and inconsistent assessment of RV function . Consequently, the prevalence of RVD in HFpEF varies widely depending on study design and population characteristics; however, on average is observed in one third of HFpEF subjects. In these patients, RVD is most commonly associated with an advanced HF state, pulmonary hypertension, atrial fibrillation, right ventricular pacing, and tricuspid valve regurgitation. Whether these associations are causal remains uncertain.Right ventricular dysfunction is recognized to confer poor outcomes in patients with HFpEF, including increased HF hospitalization and higher overall and cardiovascular mortality. Moreover, the prognostic significance of RVD in HFpEF is independent of, and additive to, the severity of pulmonary hypertension. As greater emphasis is placed on phenotyping subgroups of patients with HFpEF in order to tailor therapeutic strategies, improved characterization of the large subset of HFpEF patients with RVD, with and without antecedent pulmonary hypertension may yield critical insights, which inform novel therapeutic interventions.

Entities:  

Keywords:  Diastole; Epidemiology; Fractional area change; Heart failure with preserved ejection fraction; Pulmonary hypertension; Right ventricle; TAPSE

Mesh:

Year:  2015        PMID: 26338372     DOI: 10.1007/s11897-015-0267-3

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  47 in total

1.  Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right ventricular systolic function.

Authors:  J Meluzín; L Spinarová; J Bakala; J Toman; J Krejcí; P Hude; T Kára; M Soucek
Journal:  Eur Heart J       Date:  2001-02       Impact factor: 29.983

2.  Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

3.  Regional and global right ventricular function in healthy individuals aged 20-90 years: a pulsed Doppler tissue imaging study: Umeå General Population Heart Study.

Authors:  Per Lindqvist; Anders Waldenström; Michael Henein; Stellan Mörner; Elsadig Kazzam
Journal:  Echocardiography       Date:  2005-04       Impact factor: 1.724

Review 4.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

5.  Significant left ventricular contribution to right ventricular systolic function.

Authors:  R J Damiano; P La Follette; J L Cox; J E Lowe; W P Santamore
Journal:  Am J Physiol       Date:  1991-11

6.  Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension.

Authors:  Yan Topilsky; Amber Khanna; Thierry Le Tourneau; Soon Park; Hector Michelena; Rakesh Suri; Douglas W Mahoney; Maurice Enriquez-Sarano
Journal:  Circ Cardiovasc Imaging       Date:  2012-03-23       Impact factor: 7.792

7.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.

Authors:  T C Yeo; K S Dujardin; C Tei; D W Mahoney; M D McGoon; J B Seward
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

8.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

9.  Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Authors:  Carolyn S P Lam; Peter E Carson; Inder S Anand; Thomas S Rector; Michael Kuskowski; Michel Komajda; Robert S McKelvie; John J McMurray; Michael R Zile; Barry M Massie; Dalane W Kitzman
Journal:  Circ Heart Fail       Date:  2012-08-10       Impact factor: 8.790

10.  Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Authors:  Amil M Shah; Sanjiv J Shah; Inder S Anand; Nancy K Sweitzer; Eileen O'Meara; John F Heitner; George Sopko; Guichu Li; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2013-11-18       Impact factor: 8.790

View more
  8 in total

1.  Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction.

Authors:  Gaspare Parrinello; Daniele Torres; Silvio Buscemi; Tiziana Di Chiara; Francesco Cuttitta; Mauro Cardillo; Francesca Romana Pluchinotta; Rosario Scaglione; Salvatore Paterna; Antonio Pinto
Journal:  Intern Emerg Med       Date:  2019-03-20       Impact factor: 3.397

Review 2.  Cellular and molecular pathobiology of heart failure with preserved ejection fraction.

Authors:  Sumita Mishra; David A Kass
Journal:  Nat Rev Cardiol       Date:  2021-01-11       Impact factor: 49.421

Review 3.  Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.

Authors:  Shuai Li; Xinling Zhang; Mei Dong; Shu Gong; Zhi Shang; Xu Jia; Wenqiang Chen; Jianmin Yang; Jifu Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.

Authors:  Prathap Kanagala; Jayanth R Arnold; Anvesha Singh; Daniel C S Chan; Adrian S H Cheng; Jamal N Khan; Gaurav S Gulsin; Jing Yang; Lei Zhao; Pankaj Gupta; Iain B Squire; Leong L Ng; Gerry P McCann
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

5.  Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.

Authors:  M Louis Handoko; Frances S de Man; Jessie van Wezenbeek; Azar Kianzad; Arno van de Bovenkamp; Jeroen Wessels; Sophia A Mouratoglou; Natalia J Braams; Samara M A Jansen; Eva Meulblok; Lilian J Meijboom; J Tim Marcus; Anton Vonk Noordegraaf; Marie José Goumans; Harm Jan Bogaard
Journal:  Circ Heart Fail       Date:  2021-12-23       Impact factor: 8.790

6.  Pathophysiological Mapping of Experimental Heart Failure: Left and Right Ventricular Remodeling in Transverse Aortic Constriction Is Temporally, Kinetically and Structurally Distinct.

Authors:  Mathew J Platt; Jason S Huber; Nadya Romanova; Keith R Brunt; Jeremy A Simpson
Journal:  Front Physiol       Date:  2018-05-15       Impact factor: 4.566

7.  Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.

Authors:  Ravi B Patel; Emily Li; Brandon C Benefield; Stanley A Swat; Vincenzo B Polsinelli; James C Carr; Sanjiv J Shah; Michael Markl; Jeremy D Collins; Benjamin H Freed
Journal:  ESC Heart Fail       Date:  2020-01-05

8.  Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.

Authors:  Prathap Kanagala; Jayanth R Arnold; Anvesha Singh; Jamal N Khan; Gaurav S Gulsin; Pankaj Gupta; Iain B Squire; Leong L Ng; Gerry P McCann
Journal:  Int J Cardiovasc Imaging       Date:  2020-07-31       Impact factor: 2.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.